Electronic medical record reminder improves osteoporosis management after a fracture: A randomized, controlled trial

被引:143
作者
Feldstein, A
Elmer, PJ
Smith, DH
Herson, M
Orwoll, E
Chen, CH
Aickin, M
Swain, MC
机构
[1] Kaiser Permanente Ctr Hlth Res, Portland, OR 97227 USA
[2] NW Permanente, Portland, OR USA
[3] Oregon Hlth Sci Univ, Dept Endocrinol Bone & Mineral Osteoporosis, Portland, OR USA
[4] Univ Arizona, Tucson, AZ USA
关键词
osteoporosis treatment; bone mineral density measurement; electronic medical record;
D O I
10.1111/j.1532-5415.2005.00618.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
OBJECTIVES: Osteoporosis treatment rates after a fracture are low. This study evaluated methods to increase guideline-recommended osteoporosis care postfracture. DESIGN: Participants were randomly assigned to usual care or one of two interventions. Analysis of primary outcomes used electronic data and linear regression. SETTING: A Pacific Northwest nonprofit health maintenance organization. PARTICIPANTS: Female patients aged 50 to 89 who suffered a fracture in 1999 and had not received bone mineral density (BMD) measurement or medication for osteoporosis (n=311) and their primary care providers (n=159). INTERVENTION: Patient-specific clinical guideline advice to the primary care provider delivered by electronic medical record (EMR) message or electronic reminder to the provider plus an educational letter mailed to the patient. MEASUREMENTS: BMD measurement and osteoporosis medication. RESULTS: At 6 months, provider reminder resulted in 51.5% of patients receiving BMD measurement or osteoporosis medication, provider reminder plus patient education resulted in 43.1%, and usual care resulted in 5.9% (P <.001). The effect of provider advice combined with patient education was not significantly different from provider advice alone (P=.88). Patients aged 60 to 69 were 18% (95% confidence interval=3-34) more likely to receive BMD measurement or an osteoporosis medication than those aged 80 to 89. CONCLUSION: Patient-specific postfracture advice to the provider through an EMR message significantly increased BMD measurement and osteoporosis medication. As EMRs become more widespread, this intervention could improve osteoporosis management for many postfracture patients. Future research should identify barriers to and facilitators of care for older, high-risk patients.
引用
收藏
页码:450 / 457
页数:8
相关论文
共 43 条
  • [1] Randomization, balance, and the validity and efficiency of design-adaptive allocation methods
    Aickin, M
    [J]. JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2001, 94 (01) : 97 - 119
  • [2] Ali N S, 1994, Geriatr Nurs, V15, P201
  • [3] Improving preventive care by prompting physicians
    Balas, EA
    Weingarten, S
    Garb, CT
    Blumenthal, D
    Boren, SA
    Brown, GD
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (03) : 301 - 308
  • [4] BALAS EA, P AMIA S 1998, P295
  • [5] Risk factors associated with women's compliance with estrogen replacement therapy
    Berman, RS
    Epstein, RS
    Lydick, E
    [J]. JOURNAL OF WOMENS HEALTH, 1997, 6 (02) : 219 - 226
  • [6] Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial
    Black, DM
    Thompson, DE
    Bauer, DC
    Ensrud, K
    Musliner, T
    Hochberg, MC
    Nevitt, MC
    Suryawanshi, S
    Cummings, SR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) : 4118 - 4124
  • [7] BLACK DM, 1994, J BONE MINER RES S, V9, P135
  • [8] Effects of educational materials concerning osteoporosis on women's knowledge, beliefs, and behavior
    Blalock, SJ
    Currey, SS
    DeVellis, RF
    DeVellis, BM
    Giorgino, KB
    Anderson, JJB
    Dooley, MA
    Gold, DT
    [J]. AMERICAN JOURNAL OF HEALTH PROMOTION, 2000, 14 (03) : 161 - 169
  • [9] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [10] Cummings SR, 1998, OSTEOPOROSIS INT, V8, pS8